SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

Regeneron quarterly profit rises 45% on Eylea strength

· 02/05/2021 06:35
Regeneron quarterly profit rises 45% on Eylea strength

- Regeneron Pharmaceuticals Inc REGN.O on Friday reported a 45% rise in quarterly profit, benefiting from a recovery in demand for its flagship eye drug, Eylea, which took a hit last year due to the pandemic.

Net profit increased to $1.15 billion, or $10.24 per share, in the fourth quarter ended Dec. 31, from $792 million, or $6.93 per share, a year earlier.


(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

((manojna.kalyani@thomsonreuters.com; +91 8061822700;))